Rinucumab

Names

[ Name ]:
Rinucumab

Biological Activity

[Description]:

Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].

[Related Catalog]:

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> PDGFR

Research Areas >> Metabolic Disease

[References]

[1]. Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.